W. Bryan Hill - Sep 23, 2024 Form 4 Insider Report for ALKAMI TECHNOLOGY, INC. (ALKT)

Role
Chief Financial Officer
Signature
/s/ Douglas A. Linebarger, as Attorney-in-Fact for W. Bryan Hill
Stock symbol
ALKT
Transactions as of
Sep 23, 2024
Transactions value $
-$2,872,567
Form type
4
Date filed
9/25/2024, 05:39 PM
Previous filing
Sep 6, 2024
Next filing
Nov 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALKT Common Stock Options Exercise $129K +55K +11.68% $2.34 526K Sep 23, 2024 Direct
transaction ALKT Common Stock Sale -$1.72M -55K -10.46% $31.19 471K Sep 23, 2024 Direct F1, F2
transaction ALKT Common Stock Options Exercise $105K +45K +9.54% $2.34 516K Sep 24, 2024 Direct
transaction ALKT Common Stock Sale -$1.39M -45K -8.71% $30.92 471K Sep 24, 2024 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALKT Stock Option (Right to Buy) Options Exercise $0 -55K -13.76% $0.00 345K Sep 23, 2024 Common Stock 55K $2.34 Direct F4
transaction ALKT Stock Option (Right to Buy) Options Exercise $0 -45K -13.03% $0.00 300K Sep 24, 2024 Common Stock 45K $2.34 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 11, 2024.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transaction of prices ranging from $30.77 to $31.72. The Reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transaction of prices ranging from $30.68 to $31.29. The Reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The shares subject to the option are fully vested and exercisable.